ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669793 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669793; 2) Community: the network communities that were significantly associated with the response to NSC 669793; 3) Molecule: the relationships between components within communities and NSC 669793; 4) MDR: the compounds that were significantly associated with the NSC 669793.

NSC Compound Enrichment Correlation
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.0273093708703115 0.0018842371
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0273093708703115 -0.081942026
NSC 664314 Null 0.0273093708703115 0.16547118
NSC 675766 Null 0.0273093708703115 0.14545697
NSC 681635 Camptothecin Derivative 0.0273093708703115 -0.077556426
NSC 681639 Camptothecin Derivative 0.0273093708703115 -0.17765694
NSC 705437 Null 0.0273093708703115 -0.16764549
NSC 709447 Null 0.0273093708703115 -0.049897435
NSC 709900 Isoxazolo[5,4-d]-1,2,3-triazin-4(3H)-one, 3-(4-chlorophenyl)-5-methyl- 0.0273093708703115 -0.15856787
NSC 725670 5,6-Dihydro-5,11-dioxo-6-(2-N-piperazine-1-ethyl)-11H-indeno [1,2-c]isoquinoline 0.0273093708703115 -0.11546567
Total:28  Current:14    [First] [Prev] [Next] [Last]